LDRD : revenue, balance sheet and financial ratios

LDRD is a French company founded 8 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in TROYES (10000), this company of category PME shows in 2021 a revenue of 277 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LDRD (SIREN 830489217)
Indicator 2023 2021 2018
Revenue N/C 276 840 € 208 268 €
Net income 0 € 8 126 € -6 013 €
EBITDA N/C 19 901 € -4 351 €
Net margin N/C 2.9% -2.9%

Revenue and income statement

In 2023, LDRD records a net loss of 0 €. This deficit will reduce equity on the balance sheet.

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 38%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 21%. The balance between equity and debt is satisfactory.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

38.196%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

20.854%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

41.7%

Solvency indicators evolution
LDRD

Sector positioning

Debt ratio
38.2 2023
2018
2021
2023
Q1: 0.0
Med: 5.57
Q3: 50.77
Average -8 pts over 3 years

In 2023, the debt ratio of LDRD (38.20) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
20.85% 2023
2018
2021
2023
Q1: 13.47%
Med: 38.42%
Q3: 58.45%
Average -36 pts over 3 years

In 2023, the financial autonomy of LDRD (20.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
1.74 years 2021
2018
2021
Q1: 0.0 years
Med: 0.01 years
Q3: 1.79 years
Average +50 pts over 2 years

In 2021, the repayment capacity of LDRD (1.74) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 246.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

246.683

Liquidity indicators evolution
LDRD

Sector positioning

Liquidity ratio
246.68 2023
2018
2021
2023
Q1: 133.58
Med: 205.53
Q3: 329.15
Good +17 pts over 3 years

In 2023, the liquidity ratio of LDRD (246.68) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
14.42x 2021
2018
2021
Q1: 0.0x
Med: 0.39x
Q3: 4.57x
Excellent +50 pts over 2 years

In 2021, the interest coverage of LDRD (14.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
LDRD

Positioning of LDRD in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare LDRD with other companies in the same sector:

Frequently asked questions about LDRD

What is the revenue of LDRD ?

The revenue of LDRD in 2021 is 277 k€.

Is LDRD profitable?

Yes, LDRD generated a net profit of 8 k€ in 2021.

Where is the headquarters of LDRD ?

The headquarters of LDRD is located in TROYES (10000), in the department Aube.

Where to find the tax return of LDRD ?

The tax return of LDRD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LDRD operate?

LDRD operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.